Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration

At clinical concentrations, lidocaine significantly inhibits CXCR4 signalling. The results presented shed new insights on the molecular mechanisms governing the inhibitory effect of lidocaine on cell migration.